Turkey's biosimilar sector is emerging as one of the most closely watched segments within the country's pharmaceutical industry, supported by rising healthcare expenditure, an expanding base of patients requiring biologic therapies, and strong government emphasis on reducing the cost burden of complex medicines. Turkey biosimilar market size reached USD 422.0 Million in 2025. The market is...
French
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek